Psaty, BM, Lumley, T, Furberg, CD, Schellenbaum, G, Pahor, M, Alderman, MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA
2003; 289: 2534–44.
Peters, AL, Davidson, MB, Schriger, DL, Hasselbald, V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis research group on the diagnosis of diabetes using glycosylated hemoglybin levels. JAMA
1996; 276: 1246–52.
Adams, EK, Breen, N, Joski, PJ. Impact of the National Breast and Cervical Detection Program on mammography and pap test utilization among white, Hispanic, and African American women: 1996–2000. Cancer
2007; 109: 348–58.
Yung, AR, Phillips, LJ, Yuen, HP, McGorry, PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res
2004; 67: 131–42.
Ruhrmann, S, Schultze-Lutter, F, Salokangas, RK, Heinimaa, M, Linszen, D, Dingemans, P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry
2010; 67: 241–51.
Cannon, TD, Cadenhead, K, Conblatt, B, Woods, SW, Addington, J, Walker, E, et al. Prediction of psychosis in youth at high clinical risk: a multi-site longitudinal study in North America. Arch Gen Psychiatry
2008; 65: 28–37.
McGorry, PD, Yung, AR, Phillips, LJ. The ‘close-in’ or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull
2003; 29: 771–90.
McGorry, PD, Yung, AR, Phillips, LJ, Yuen, HP, Francey, S, Cosgrave, EM, et al. Can first episode psychosis be delayed or prevented? A randomized controlled trial of interventions during the prepsychotic phase of schizophrenia and related psychosis. Arch Gen Psychiatry
2002; 59: 921–8.
Morrison, AP, French, P, Walford, L, Lewis, SW, Kilcommons, A, Green, J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk. randomised controlled trial. Br J Psychiatry
2004; 185: 291–7.
Addington, J, Epstein, I, Liu, L, French, P, Boydell, KM, Zipursky, RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res
2011; 125: 54–61.
McGlashan, TH, Zipursky, RB, Perkins, D, Addington, J, Miller, T, Woods, SW, et al. A randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry
Amminger, GP, Schäfer, MR, Papageorgiou, K, Klier, CM, Cotton, SM, Harrigan, SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry
2010; 67: 146–54.
Morrison, AP, French, P, Parker, S, Roberts, M, Stevens, H, Bentall, RP, et al. Three year follow-up of a randomised controlled trial of cognitive therapy for the prevention of psychosis in people at ultra-high risk. Schizophr Bull
2007; 33: 682–7.
Phillipps, LJ, McGorry, PD, Yuen, HP, Ward, J, Donovan, K, Kelly, D, et al. Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Shizophr Res
2007; 96: 25–33.
Klosterkötter, J, Hellmich, M, Steinmeyer, EM, Schultze-Lutter, F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry
2001; 58: 158–64.
Gross, G, Huber, G. Psychopathology of basic stages of schizophrenia in view of formal thought disturbances. Psychopathology
1985; 18: 115–25.
Bechdolf, A, Pukrop, R, Köhn, D, Tschinkel, S, Schultze-Lutter, F, Ruhrmann, S, et al. Subjective quality of life in subjects at risk for first episode psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophr Res
2005; 79: 137–41.
Brockhaus-Dumke, A, Ruhrmann, S, Tendolkar, I, Pukrop, R, Klosterkötter, J. Impaired mismatch negativity (MMN) generation in prodromal and schizophrenia patients. Schizophr Res
2005; 73: 297–310.
Pukrop, R, Schultze-Lutter, F, Ruhrmann, S, Brockhaus-Dumke, A, Tendolkar, I, Bechdolf, A, et al. Neurocognitive indicators for a transition to psychosis: comparison of subjects at risk who transited to psychosis and who did not transit. Schizophrenia Res
2007; 92: 116–25.
Bechdolf, A, Ruhrmann, S, Wagner, M, Kühn, KU, Janssen, B, Bottlender, R, et al. Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment. Br J Psychiatry
2005; 187 (suppl 48): s45–8.
Häfner, H, Maurer, K, Ruhrmann, S, Bechdolf, A, Klosterkötter, J, Wagner, M, et al. Are early detection and secondary prevention feasible? Facts and visions. Eur Arch Psychiatry Clin Neurosci
2004; 254: 117–28.
Jones, C, Cormac, I, Silveira da Mota Neto, JI, Campbell, C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev
2004; 4: CD000524.
Pilling, S, Bebbington, P, Kuipers, E, Garety, P, Geddes, J, Orbach, G, et al. Psychological treatment in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med
2002; 32: 763–82.
Penn, DL, Waldheter, EJ, Perkins, DO, Mueser, KT, Lieberman, JA. Psychosocial treatment for first-episode psychosis. A research update. Am J Psychiatry
2005; 162: 220–32.
Work Group on Panic Disorder, American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry
1998; 155 (suppl 5): 1–34.
American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry
2000; 157 (suppl 4): 1–45.
Haefner, H, Bechdolf, A, Klosterkötter, J, Maurer, K. Early Detection and Intervention in Psychosis. A Practise Handbook. Schattauer, 2011.
Cannon, M, Jones, PB, Murray, RM. Obstetric complications and schizophrenia: historical and meta-analysis. Am J Psychiatry
2002; 159: 1080–92.
Geddes, JR, Lawrie, SM. Obstetric complications and schizophrenia: a meta-analysis. Br J Psychiatry
1995; 167: 786–93.
Nuechterlein, KH, Dawson, ME. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull
1984; 10: 300–12.
Larsen, TK, Bechdolf, A, Birchwood, M. The concept of schizophrenia and phase specific treatment. Psychological treatment in pre-psychosis and non-responders. J Am Acad Psychoanal Dyn Psychiatry
2003; 31: 209–28.
Chadwick, PDJ, Birchwood, M, Trower, P. Cognitive Therapy for Delusions, Voices and Paranoia. John Wiley & Sons, 1996.
Fowler, D, Garety, P, Kuipers, E. Cognitive Behaviour Therapy for People with Psychosis. John Wiley & Sons, 1995.
Kingdon, D, Turkington, D. Cognitive-Behavioural Therapy for Schizophrenia. Lawrence Erlbaum, 1995.
Beck, AT. Cognitive Therapy and the Emotional Disorders. International University Press, 1976.
Bechdolf, A, Puetzfeld, V, Gross, S, Guettgemanns, J. Cognitive Behavioural Therapy in People at Risk of Psychosis. Huber, 2010.
Bechdolf, A, Veith, V, Klosterkötter, J. Group intervention for people at high risk of developing psychosis. In Working with People at Ultra-high Risk of Developing Psychosis (eds Addington, J, Francey, SH, Morrison, AP): 169–81. John Wiley & Sons, 2006.
Bechdolf, A, Phillips, LJ, Francey, S, Leicester, S, Morrison, AP, Veith, V, et al. Recent approaches to psychological interventions for people at risk of psychosis. European Arch Psychiatry Clin Neuroscience
2006: 256: 159–73
Bechdolf, A, Veith, V, Berning, J, Stamm, E, Janssen, B, Wagner, M, et al. Cognitive-behavioural therapy in the pre-psychotic phase. An exploratory study. Psychiatr Res
2005; 136: 251–5.
Häfner, H, Riecher-Rössler, A, Hambrecht, M, Maurer, K, Meissner, S, Schmidtke, A, et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res
1992; 6: 209–23.
Lewis, SW, Murray, RM. Obstetric complications, neurodevelopment deviance and risk of schizophrenia. J Psychiatr Res
1987; 21: 413–21.
Kay, SR, Opler, LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull
1987; 13: 507–18.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition)
. APA, 1994.
Cicchetti, DV, Sparrow, SA. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behaviour. Am J Ment Defic
1981; 86: 127–37.
Cook, RJ, Sackett, DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ
1995; 310: 452–4.
Tarrier, N, Wykes, T. Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?
Behav Res Ther
2004; 42: 1377–401.